摘要:
An artificial cornea capable of preventing a separation thereof from an eyeball of the patient during an implant operation thereof while avoiding post-operative complications at the interface between the artificial cornea and the patient's cornea, such as erosive tissue necrosis (melting), leakage of aqueous humor, infection, extrusion of the implant, and intraocular inflammation. The artificial cornea includes an artificial cornea body having, at a lower portion thereof, a cylindrical portion adapted to be arranged in the interior of a patient's eyeball, and, at an upper portion thereof, an optical portion adapted to be exposed through an anterior portion of the patient's eyeball, the optical portion having a diameter less than that of the cylindrical portion to define a step at a lower end thereof, a skirt fitted around the optical portion of the cornea body and seated on the step, an anterior flange coupled to an upper surface of the skirt, and a support member attached to a lower end of the cylindrical portion and adapted to support the artificial cornea body. An amnion is covered on the implant in order to promote a stable graft of the artificial cornea to the patient's cornea during an initial reaction period for the recovery of a cut portion of the patient's cornea.
摘要:
Disclosed is an ophthalmic applicator for the treatment of pterygium or or glaucoma using a radioisotope. It comprises a source volume for containing the radioisotope therein; a filter volume for controlling a radiation dose emitted from the radioisotope; and an encapsulation volume for encompassing the source volume and the filter volume, wherein the radioisotope is pure 32P or a combination of 32P and 103Pd. Ensuring the formation of more ideal dose distributions than do the conventional 90Sr ophthalmic applicators, as described hitherto, the ophthalmic applicator for the treatment of pterygium or glaucoma using 32P or a combination of 32P and 103Pd can promise both high therapeutic effects on pterygium or glaucoma and high safety effects on the eye lens. Further, 32P and 103Pd are easier to produce and treat than is 90Sr, thereby allowing the radiotherapy to be useful.
摘要:
Disclosed is a method for processing porcine cornea using an aqueous NaCl solution and an aqueous trypsin/EDTA solution to decellularize enucleated porcine cornea. The porcine cornea processed by the method causes neither inflammation nor immune rejection. The porcine corneal stroma decellularized by the method can be recellularized together with host keratocytes after transplantation.
摘要:
Disclosed is a method for processing porcine cornea using an aqueous NaCl solution and an aqueous trypsin/EDTA solution to decellularize enucleated porcine cornea. The porcine cornea processed by the method causes neither inflammation nor immune rejection. The porcine corneal stroma decellularized by the method can be recellularized together with host keratocytes after transplantation.